Related Experiment Video

Updated: Aug 20, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Modulation of cellular differentiation and cell fate for cancer therapy

Laure A Moutouh-de Parseval1, Kyle W H Chan

  • 1Celgene, 4550 Towne Centre Court, San Diego, CA 92121, USA.

Current Opinion in Investigational Drugs (London, England : 2000)
|January 15, 2005
PubMed

Insights

Cancer stem cells, implicated in neoplastic diseases, are targeted by new therapies. Drugs influencing stem cell differentiation offer novel treatment strategies for malignant diseases.

Area of Science:

  • Developmental biology
  • Cancer biology
  • Stem cell research

Background:

  • Neoplastic diseases may arise from dysregulated stem cell differentiation and proliferation.
  • Cancer stem cells (CSCs) are identified in various cancers, including leukemia and breast tumors.
  • Therapeutic agents impacting differentiation, like retinoic acid, are effective in treating certain leukemias.

Purpose of the Study:

  • To explore the role of stem cell biology in cancer.
  • To highlight the potential of targeting stem cell differentiation for cancer treatment.
  • To discuss novel therapeutic modalities for malignant diseases.

Main Methods:

  • Review of current literature on stem cell biology and cancer.
  • Analysis of the role of stem cell differentiation in tumorigenesis.
  • Examination of existing and potential therapeutic strategies targeting cancer stem cells.

Main Results:

  • Dysregulation of fundamental developmental processes is linked to cancer.
  • Cancer stem cells represent a viable target for therapeutic intervention.
  • Targeting cell fate and differentiation pathways holds promise for cancer management.

Conclusions:

  • Understanding stem cell biology is crucial for advancing cancer treatment.
  • Developing drugs that modulate stem cell differentiation and cell fate is a promising therapeutic avenue.
  • Targeted therapies offer new hope for managing and treating malignant diseases.

More Related Videos

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...